论文部分内容阅读
维吾尔医尚无符合维吾尔医药理论体系的维吾尔药新药临床研究指导原则。本文针对白癜风维吾尔医诊疗方案进行多中心临床病历回顾性调查研究,收集人口学、诊断学、治疗学、疗效评价、护理学资料等信息,进行整理研究分析。确定了白癜风维吾尔医证候要素的诊断指标及其贡献度,建立了以其维吾尔医主证和次症条目及其症状量化表为证候要素的维吾尔医辨证分型标准,并根据白斑面积、色素再生疗效评价指标,结合维吾尔医主症和次症变化,建立了此病的维吾尔医疗效评价标准。在此基础上,按照国家新药审评的技术要求,研究制订了维吾尔药新药治疗白癜风的临床研究指导原则。
Uighur medicine still does not meet the Uyghur medicine theoretical system of Uygur medicine new drug clinical research guidelines. In this paper, we retrospectively investigated the multi-center clinical medical records of Uyghur medical diagnosis and treatment programs and collected demographic, diagnostic, therapeutic, efficacy evaluation, nursing information and other information to conduct the research. The diagnostic criteria and contribution degree of Uyghur cardinitis elements in vitiligo were established, and the Uyghur carding criteria was established based on the Uyghur physician’s syndrome and sub-symptom items and its symptom quantification table. According to the white spot area, Pigment regeneration efficacy evaluation index, combined with the change of the main and minor symptoms of the Uyghur physician, established the Uighur medical evaluation standard. On this basis, in accordance with the national new drug review and technical requirements, research and formulate a new drug Uygur clinical treatment of vitiligo guidelines.